FHAM
AMAG

Folger Hill Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Folger Hill Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-300,586
Closed -$7.03M – 245
2016
Q1 		$7.03M Buy
300,586
+22,986
+8% +$546K 0.39% 63
2015
Q4 		$8.38M Buy
+277,600
New +$8.97M 0.51% 58

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Folger Hill Asset Management's AMAG Position: Q2 2016 in Review

Folger Hill Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2016, closing a stake of 300,586 shares — an estimated $7.03M sold.

Folger Hill Asset Management first reported a position in AMAG in Q4 2015 and held it in 2 quarters. The position peaked at $8.38M in Q4 2015. 165 funds tracked by Wall St. Rank hold AMAG as of Q2 2016.

  • Folger Hill Asset Management reported no remaining AMAG Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Folger Hill Asset Management sold 300,586 AMAG Pharmaceuticals shares in Q2 2016, an estimated $7.03M.
  • Folger Hill Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 2 quarters.
  • Folger Hill Asset Management's AMAG Pharmaceuticals position peaked at $8.38M in Q4 2015.
  • 165 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2016.

Based on Folger Hill Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.